Proatherogenic Oxidized Low-Density Lipoprotein/2-Glycoprotein I Complexes in Arterial and Venous Disease

Table 2

Odds ratio (OR) for arterial or venous disease by oxLDL/β2GPI quartiles.

OxLDL/β2GPI quartiles*	Arterial		Venous
	OR (95% CI)^∧	value**	OR (95% CI)^∧	value**
Q2	1.25 (0.213–7.354)	0.805	6.25 (0.641–60.938)	0.085
Q3	4.44 (0.931–21.218)	0.053	18.3 (2.016–166.725)	0.002
Q4	5.42 (1.249–23.489)	0.018	10.0 (1.093–91.441)	0.020
Q1 + 2 versus Q3 + 4	4.50 (1.541–13.140)	0.004	4.10 (1.382–11.996)	0.008

OxLDL/β2GPI quartiles: Q1 = 0–0.17; Q2 = 0.18–0.25; Q3 = 0.26–0.57; Q4 = 0.58–1.4 U/mL. The association increased significantly with oxLDL/2GPI quartiles for arterial () and venous disease () (Cochran-Armitage Trend test).
^∧Odds ratio (95% confidence interval).
**Pearson’s Chi-square against Q1.